Creative Proteomics Cytokine Unveils Tumor Necrosis Factors (TNF) Detection Service

New York, NY, United States – May 20, 2022 /MarketersMEDIA/ —

The Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics Cytokine recently announced the launch of the high-sensitivity Tumor Necrosis Factors (TNF) Detection Service to help with your TNF research.

Tumor Necrosis Factor (TNF) is a cell-signaling protein involved in the acute phase immunologic reactions along with other cytokines. It is produced by a variety of cells, chiefly macrophages and neutrophils but also mast cells, eosinophils, and NK cells. TNF’s primary role involves the regulation of immune cells, but it is also a pyrogen that induces fever and inflammation. In addition, TNF can inhibit viral replication and respond to sepsis by inducing Interleukins 1 and 6. It is one of the earliest cytokines produced and may have both a direct effect on cells and tissues and an indirect effect on inducing cell types to produce other cytokines.

“Creative Proteomics has multiple TNF detection platforms such as multiplex Luminex, flow cytometry, and ELISA. We will choose the right technology combination according to your project, meet your various needs, and help researchers obtain higher-quality scientific research data,” stated Creative Proteomics’s senior scientist.

Creative Proteomics can provide a tumor necrosis factor detection platform for scientific research. Professional analysts can customize exclusive solutions for you according to different purposes. The following are the types of TNF that can be detected:

1. TNF-α Detection Service
2. TNF-β Detection Service

“Creative Proteomics mainly uses the Luminex cytokine detection platform for cytokine detection. Our dedicated analysts will customize exclusive solutions for you according to different purposes. Our Luminex cytokine detection platform uses fluorescently encoded microspheres with specific antibodies to different target molecules. The various microspheres can be combined freely to a certain extent so that up to 100 analytes can be tested multiple times simultaneously in a single experiment,” he further added.

About Creative Proteomics

Creative Proteomics is an innovative contract research organization that focuses on using advanced equipment platforms and optimized detection technology to help researchers around the world reduce time and costs. The company has a proprietary laboratory information management system to strengthen laboratory quality monitoring and quality management to ensure the efficiency and security of customer data.

Contact Info:
Name: Melissa George
Email: Send Email
Organization: Creative Proteomics
Address: Shirley, New York 11967
Phone: (631) 593-0501
Website: https://cytokine.creative-proteomics.com/

Release ID: 89075426

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.